19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Other Related Categories

514178, 514179, 514182, 514181, 552539, 552526, 552515, 552561, 552588, 552587, 552583, 552600, 552601, 552602, C07J 100, A61K 3156

Type

Patent

Status

active

Patent number

049201140

Description

ABSTRACT:
19-Fluoro- and cyano- substituted 21-hydroxyprogesterone derivatives and related compounds which are active as 19-hydroxylase inhibitors and useful as antihypertensive agents are described herein. The compounds are prepared using appropriate synthetic pathways which will vary according to the nature of the specific 19-substituted progesterone or related compound desired.

REFERENCES:
patent: 3124574 (1964-03-01), Bowers
patent: 3154569 (1964-10-01), Ercoli et al.
patent: 3159620 (1964-12-01), Ercoli et al.
patent: 3186988 (1965-06-01), Bowers
patent: 3214427 (1965-10-01), Ercoli et al.
patent: 3257389 (1966-06-01), Bowers
patent: 3257435 (1966-06-01), Bowers et al.
patent: 3394128 (1968-07-01), Edwards

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 19-fluoro- or cyano-21-hydroxyprogesterone derivatives useful as will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-34869

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.